157 related articles for article (PubMed ID: 38512023)
1. Association of Impaired Left Ventricular Mitral Filling from 4D Flow Cardiac MRI and Prognosis of Hypertrophic Cardiomyopathy.
Sakhi H; Soulat G; Craiem D; Gencer U; Lamy J; Stipechi V; Puscas T; Hulot JS; Hagege A; Mousseaux E
Radiol Cardiothorac Imaging; 2024 Apr; 6(2):e230198. PubMed ID: 38512023
[TBL] [Abstract][Full Text] [Related]
2. Cardiac MRI e-prime predicts myocardial late gadolinium enhancement and diastolic dysfunction in hypertrophic cardiomyopathy.
O'Brien AC; MacDermott R; Keane S; Ryan DT; McVeigh N; Durand R; Ferre M; Murphy DJ; Teekakirikul P; Keane D; McDonald K; Ledwidge M; Dodd JD
Eur J Radiol; 2022 Apr; 149():110192. PubMed ID: 35158215
[TBL] [Abstract][Full Text] [Related]
3. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization.
Geske JB; Sorajja P; Nishimura RA; Ommen SR
Circulation; 2007 Dec; 116(23):2702-8. PubMed ID: 18025528
[TBL] [Abstract][Full Text] [Related]
5. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of left ventricular end diastolic pressure using E/E' in patients with hypertrophic cardiomyopathy.
Badran HM; Soltan G; Almeleigi R; Faheem N; Yacoub MH
Echocardiography; 2019 Dec; 36(12):2167-2175. PubMed ID: 31742769
[TBL] [Abstract][Full Text] [Related]
8. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
[TBL] [Abstract][Full Text] [Related]
9. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide is related with coronary flow velocity reserve and diastolic dysfunction in patients with asymmetric hypertrophic cardiomyopathy.
Tesic M; Seferovic J; Trifunovic D; Djordjevic-Dikic A; Giga V; Jovanovic I; Petrovic O; Marinkovic J; Stankovic S; Stepanovic J; Ristic A; Petrovic M; Mujovic N; Vujisic-Tesic B; Beleslin B; Vukcevic V; Stankovic G; Seferovic P
J Cardiol; 2017 Oct; 70(4):323-328. PubMed ID: 28336204
[TBL] [Abstract][Full Text] [Related]
11. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
Lu DY; Ventoulis I; Liu H; Kudchadkar SM; Greenland GV; Yalcin H; Kontari E; Goyal S; Corona-Villalobos CP; Vakrou S; Zimmerman SL; Abraham TP; Abraham MR
Am Heart J; 2020 Jan; 219():58-69. PubMed ID: 31726421
[TBL] [Abstract][Full Text] [Related]
13. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
[TBL] [Abstract][Full Text] [Related]
14. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
[TBL] [Abstract][Full Text] [Related]
15. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
16. Patterns of Replacement Fibrosis in Hypertrophic Cardiomyopathy.
Liu J; Zhao S; Yu S; Wu G; Wang D; Liu L; Song J; Zhu Y; Kang L; Wang J; Song L
Radiology; 2022 Feb; 302(2):298-306. PubMed ID: 34726536
[TBL] [Abstract][Full Text] [Related]
17. Role of Doppler Diastolic Parameters in Differentiating Physiological Left Ventricular Hypertrophy from Hypertrophic Cardiomyopathy.
Finocchiaro G; Dhutia H; D'Silva A; Malhotra A; Sheikh N; Narain R; Ensam B; Papatheodorou S; Tome M; Sharma R; Papadakis M; Sharma S
J Am Soc Echocardiogr; 2018 May; 31(5):606-613.e1. PubMed ID: 29482976
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.
Pacileo G; De Cristofaro M; Russo MG; Sarubbi B; Pisacane C; Calabrò R
Can J Cardiol; 2000 Feb; 16(2):146-52. PubMed ID: 10694584
[TBL] [Abstract][Full Text] [Related]
19. Effect of Obesity on Left Ventricular Remodeling and Clinical Outcome in Chinese Patients With Hypertrophic Cardiomyopathy: Assessed by Cardiac MRI.
Shi K; Huang S; Li X; Xu HY; Yang MX; Li Y; Guo YK; Yang ZG
J Magn Reson Imaging; 2023 Mar; 57(3):800-809. PubMed ID: 35715897
[TBL] [Abstract][Full Text] [Related]
20. MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.
Xu J; Zhuang B; Sirajuddin A; Li S; Huang J; Yin G; Song L; Jiang Y; Zhao S; Lu M
Radiology; 2020 Feb; 294(2):275-286. PubMed ID: 31769741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
